- Home
- CUBI vs CNTA Comparison
CUBI vs CNTA Comparison
Compare CUBI & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUBI
- CNTA
- Stock Information
- Founded
- CUBI 1994
- CNTA 2020
- Country
- CUBI United States
- CNTA United Kingdom
- Employees
- CUBI N/A
- CNTA N/A
- Industry
- CUBI Major Banks
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- CUBI Finance
- CNTA Health Care
- Exchange
- CUBI Nasdaq
- CNTA Nasdaq
- Market Cap
- CUBI 1.4B
- CNTA 1.8B
- IPO Year
- CUBI 2012
- CNTA 2021
- Fundamental
- Price
- CUBI $51.27
- CNTA $12.18
- Analyst Decision
- CUBI Buy
- CNTA Strong Buy
- Analyst Count
- CUBI 10
- CNTA 10
- Target Price
- CUBI $65.44
- CNTA $26.11
- AVG Volume (30 Days)
- CUBI 293.2K
- CNTA 663.9K
- Earning Date
- CUBI 04-24-2025
- CNTA 05-20-2025
- Dividend Yield
- CUBI N/A
- CNTA N/A
- EPS Growth
- CUBI N/A
- CNTA N/A
- EPS
- CUBI 3.98
- CNTA N/A
- Revenue
- CUBI $591,500,000.00
- CNTA N/A
- Revenue This Year
- CUBI $15.09
- CNTA N/A
- Revenue Next Year
- CUBI $9.29
- CNTA N/A
- P/E Ratio
- CUBI $12.85
- CNTA N/A
- Revenue Growth
- CUBI N/A
- CNTA N/A
- 52 Week Low
- CUBI $40.75
- CNTA $7.75
- 52 Week High
- CUBI $68.49
- CNTA $19.09
- Technical
- Relative Strength Index (RSI)
- CUBI 58.88
- CNTA 43.78
- Support Level
- CUBI $49.81
- CNTA $11.88
- Resistance Level
- CUBI $52.26
- CNTA $14.39
- Average True Range (ATR)
- CUBI 1.59
- CNTA 0.79
- MACD
- CUBI 0.47
- CNTA 0.01
- Stochastic Oscillator
- CUBI 91.16
- CNTA 29.18
About CUBI Customers Bancorp Inc
Customers Bancorp Inc is a bank holding company engaged in banking activities. It provides financial products and services to small and middle-market businesses, not-for-profits, and consumers. The company operates in Lending Activities, Commercial Lending, Consumer Lending, Private Banking, Deposit Products, Other Funding Sources and Financial Products and Services. The majority of revenue is derived from commercial lending.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.